Global Industrial Hemp in Medical Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Industrial Hemp in Medical Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Industrial hemp is varieties of Cannabis sativa that have a tetrahydrocannabinol (THC) content generally below 0.35 percent.
Industrial Hemp in Medical report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Industrial Hemp in Medical market is projected to reach US$ 1012.7 million in 2034, increasing from US$ 804 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Industrial Hemp in Medical industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Industrial Hemp in Medical key manufacturers include Botanical Genetics, Boring Hemp, HempFlax, Isodiol, Tilray, HMI Group, Jinzhou Qiaopai Biotech, Yunnan Industrial Hemp and Shanghai Shunho New Materials Technology, etc. Botanical Genetics, Boring Hemp, HempFlax are top 3 players and held % sales share in total in 2022.
Industrial Hemp in Medical can be divided into Cannabinoid Groups and Non-Cannabinoid Groups, etc. Cannabinoid Groups is the mainstream product in the market, accounting for % sales share globally in 2022.
Industrial Hemp in Medical is widely used in various fields, such as Hospitals, Clinics and Medical Research Centers,, etc. Hospitals provides greatest supports to the Industrial Hemp in Medical industry development. In 2022, global % sales of Industrial Hemp in Medical went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Industrial Hemp in Medical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Botanical Genetics
Boring Hemp
HempFlax
Isodiol
Tilray
HMI Group
Jinzhou Qiaopai Biotech
Yunnan Industrial Hemp
Shanghai Shunho New Materials Technology
CHENGZHI
Zhejiang CONBA Pharmaceutical
Dezhan Healthcare
Kunming Longjin Pharmaceutical
Segment by Type
Cannabinoid Groups
Non-Cannabinoid Groups
Hospitals
Clinics
Medical Research Centers
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Industrial Hemp in Medical market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Industrial Hemp in Medical, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Industrial Hemp in Medical industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Industrial Hemp in Medical in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Industrial Hemp in Medical introduction, etc. Industrial Hemp in Medical Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Industrial Hemp in Medical market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Industrial Hemp in Medical report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Industrial Hemp in Medical market is projected to reach US$ 1012.7 million in 2034, increasing from US$ 804 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Industrial Hemp in Medical industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Industrial Hemp in Medical key manufacturers include Botanical Genetics, Boring Hemp, HempFlax, Isodiol, Tilray, HMI Group, Jinzhou Qiaopai Biotech, Yunnan Industrial Hemp and Shanghai Shunho New Materials Technology, etc. Botanical Genetics, Boring Hemp, HempFlax are top 3 players and held % sales share in total in 2022.
Industrial Hemp in Medical can be divided into Cannabinoid Groups and Non-Cannabinoid Groups, etc. Cannabinoid Groups is the mainstream product in the market, accounting for % sales share globally in 2022.
Industrial Hemp in Medical is widely used in various fields, such as Hospitals, Clinics and Medical Research Centers,, etc. Hospitals provides greatest supports to the Industrial Hemp in Medical industry development. In 2022, global % sales of Industrial Hemp in Medical went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Industrial Hemp in Medical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Botanical Genetics
Boring Hemp
HempFlax
Isodiol
Tilray
HMI Group
Jinzhou Qiaopai Biotech
Yunnan Industrial Hemp
Shanghai Shunho New Materials Technology
CHENGZHI
Zhejiang CONBA Pharmaceutical
Dezhan Healthcare
Kunming Longjin Pharmaceutical
Segment by Type
Cannabinoid Groups
Non-Cannabinoid Groups
Segment by Application
Hospitals
Clinics
Medical Research Centers
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Industrial Hemp in Medical market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Industrial Hemp in Medical, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Industrial Hemp in Medical industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Industrial Hemp in Medical in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Industrial Hemp in Medical introduction, etc. Industrial Hemp in Medical Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Industrial Hemp in Medical market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices